FDA DEVICE FACTS
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
DEEPVESSEL Plaque is coronary-analysis software for analysis of computed-tomography angiography DICOM data from patients aged 22 years or older with suspected or known coronary artery disease. It provides the presence and extent of coronary plaque and stenosis in patients who underwent coronary CTA for evaluation of suspected or known disease. Some views use data interpolated from the original data set; such data may appear to show healthy tissue when pathology is near or smaller than the scanning resolution. Results support qualified clinicians in evaluating and assessing coronary arteries and must be used with the patient's clinical history, symptoms, other diagnostic tests, and the clinician's professional judgment. The software does not replace the skill and judgment of a qualified medical practitioner and is limited to appropriately trained users.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。